Digital and Social Media/ News Celgene hopes device + drug can tackle aggressive brain tumours Marco Ricci brain tumours, Celgene, digital health, glioblastoma, medical devices, Novocure, Oncology, Optune 0 Comment Novocure’s Optune will be tested alongside investigational Celgene drug marizomib. Share X Celgene hopes device + drug can tackle aggressive brain tumours https://pharmaphorum.com/news/celgene-optune/
Articles/ Digital and Social Media/ Views and analysis Digital health round-up: Making a difference in brain disorders Marco Ricci brain disorders, digital health, Funding, Optune, Stentrode, Theranos 0 Comment Is digital the true solution to brain disorders? Share X Digital health round-up: Making a difference in brain disorders https://pharmaphorum.com/views-and-analysis/digital-health-round-making-difference-brain-disorders/
Digital and Social Media/ News Head patch device Optune improves brain cancer survival Marco Ricci brain cancer, glioblastoma, medical devices, Novocure, Optune 0 Comment Median overall survival improved from 15 months to 21 months when combined with chemotherapy. Share X Head patch device Optune improves brain cancer survival https://pharmaphorum.com/news/head-patch-device-optune-improves-brain-cancer-survival/
Digital and Social Media/ News Electrical patch device shows promise against ovarian cancer Marco Ricci glioblastoma, medical devices, Novocure, Optune, ovarian cancer, TTFs 0 Comment Novocure’s Optune device shown to be safe and tolerable in recurrent ovarian cancer. Share X Electrical patch device shows promise against ovarian cancer https://pharmaphorum.com/news/non-invasive-brain-tumour-patch-shows-promise-ovarian-cancer/